Ravi A Madan M.D. (@dr_ravimadan) 's Twitter Profile
Ravi A Madan M.D.

@dr_ravimadan

Clinical researcher focused on #ProstateCancer, early recurrence (#BCR) & #immunotherapy. Views are my own & do not represent the National Cancer Institute

ID: 746355556458323968

calendar_today24-06-2016 14:53:26

3,3K Tweet

2,2K Takipçi

304 Takip Edilen

Ravi A Madan M.D. (@dr_ravimadan) 's Twitter Profile Photo

Most expected #Arches 5 yr follow up data to be pro-forma @asco #ASCO25 But then this data popped up 👀 Less clear benefit of Enza+ADT in low volume #mCSPC Should this raise ?s for #mCSPC intensification w/#parp & #LU-psma Implications for over treating PSMA+ recurrence?

Most expected #Arches 5 yr follow up data to be pro-forma @asco #ASCO25

But then this data popped up 👀
Less clear benefit of Enza+ADT in low volume #mCSPC 

Should this raise ?s for #mCSPC intensification w/#parp & #LU-psma 

Implications for over treating PSMA+ recurrence?